JPH10500963A - アミノカルボン酸、ペプチドまたはカルボン酸スペーサーを有する３’−（４’−）非放射性標識ヌクレオシドおよびヌクレオチド - Google Patents

アミノカルボン酸、ペプチドまたはカルボン酸スペーサーを有する３’−（４’−）非放射性標識ヌクレオシドおよびヌクレオチド

Info

Publication number
JPH10500963A
JPH10500963A JP8500261A JP50026195A JPH10500963A JP H10500963 A JPH10500963 A JP H10500963A JP 8500261 A JP8500261 A JP 8500261A JP 50026195 A JP50026195 A JP 50026195A JP H10500963 A JPH10500963 A JP H10500963A
Authority
JP
Japan
Prior art keywords
group
compound
amino
minutes
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8500261A
Other languages
English (en)
Japanese (ja)
Inventor
ファウルシュティッヒ，コンラッド
ブラントナー，ジークフリード
ヴェヒゼルバーガー，ライナー
エンゲルス，ヨアヒン
グリージンガー，クリスチャン
Original Assignee
ベーリンガー マンハイム ゲーエムベーハー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー マンハイム ゲーエムベーハー filed Critical ベーリンガー マンハイム ゲーエムベーハー
Publication of JPH10500963A publication Critical patent/JPH10500963A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
JP8500261A 1994-05-28 1995-05-23 アミノカルボン酸、ペプチドまたはカルボン酸スペーサーを有する３’−（４’−）非放射性標識ヌクレオシドおよびヌクレオチド Pending JPH10500963A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4418691A DE4418691A1 (de) 1994-05-28 1994-05-28 3'-(4'-) nicht-radioaktiv markierte Nukleoside und Nukleotide mit Aminocarbonsäure-, Peptid- oder Carbonsäure-Spacer
DE4418691.6 1994-05-28
PCT/EP1995/001950 WO1995032985A1 (de) 1994-05-28 1995-05-23 3'-(4'-)nicht-radioaktiv markierte nukleoside und nukleotide mit aminocarbonsäure-, peptid- oder carbonsäure-spacer

Publications (1)

Publication Number Publication Date
JPH10500963A true JPH10500963A (ja) 1998-01-27

Family

ID=6519216

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8500261A Pending JPH10500963A (ja) 1994-05-28 1995-05-23 アミノカルボン酸、ペプチドまたはカルボン酸スペーサーを有する３’−（４’−）非放射性標識ヌクレオシドおよびヌクレオチド

Country Status (6)

Country Link
EP (1) EP0763051A1 (de)
JP (1) JPH10500963A (de)
CA (1) CA2190982A1 (de)
DE (1) DE4418691A1 (de)
WO (1) WO1995032985A1 (de)
ZA (1) ZA954333B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637650B2 (en) 2003-11-05 2014-01-28 Genovoxx Gmbh Macromolecular nucleotide compounds and methods for using the same
WO2011050938A1 (de) 2009-10-26 2011-05-05 Genovoxx Gmbh Konjugate von nukleotiden und methoden zu deren anwendung

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2586704B1 (fr) * 1985-09-04 1987-12-18 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation et a un groupe chimique activable, leur synthese et leurs applications a titre de nucleases artificielles specifiques de sequences. centre national de la recherche scientifique (cnrs)
FR2596761B1 (fr) * 1986-04-08 1988-05-20 Commissariat Energie Atomique Derives de nucleosides et leur utilisation pour la synthese d'oligonucleotides
DE3788914T2 (de) * 1986-09-08 1994-08-25 Ajinomoto Kk Verbindungen zur Spaltung von RNS an eine spezifische Position, Oligomere, verwendet bei der Herstellung dieser Verbindungen und Ausgangsprodukte für die Synthese dieser Oligomere.
WO1988004301A1 (fr) * 1986-12-02 1988-06-16 Centre National De La Recherche Scientifique (Cnrs OLIGONUCLEOTIDES alpha
US4962045A (en) * 1988-05-02 1990-10-09 The Perkin-Elmer Corporation Time-resolved fluorimetric detection of lanthanide labeled nucleotides
JPH0275957A (ja) * 1988-09-13 1990-03-15 Kao Corp Ｄｎａの蛍光色素標識方法
JPH0275958A (ja) * 1988-09-13 1990-03-15 Kao Corp Ｄｎａ検出法
DE3916595A1 (de) * 1989-05-22 1990-11-29 Boehringer Mannheim Gmbh Verfahren zur nichtradioaktiven messung der nucleinsaeuresynthese in eukaryontischen zellen
DE3916871A1 (de) * 1989-05-24 1990-11-29 Boehringer Mannheim Gmbh Modifiziertes phosphoramidit-verfahren zur herstellung von modifizierten nukleinsaeuren
DK0497875T3 (da) * 1989-10-24 2000-07-03 Gilead Sciences Inc 2'-modificerede oligonukleotider
YU187991A (sh) * 1990-12-11 1994-09-09 Hoechst Aktiengesellschaft 3-(2)-amino-ali tiol-modifikovani, s fluorescentnom bojom vezani nukleozidi, nukleotidi i oligonukleotidi, postupak za njihovo dobijanje i njihova upotreba
CA2084405A1 (en) * 1991-04-11 1992-10-12 Chao-Huei Jeffrey Wang Detection of dna/rna by fluorescence polarization
JP2562862B2 (ja) * 1991-08-28 1996-12-11 ベーリンガー・マンハイム・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 鋳型依存性酵素的核酸合成用プライマーとしてのオリゴヌクレオチド同時合成および直接標識化のための機能性担体
US5646261A (en) * 1992-01-22 1997-07-08 Hoechst Aktiengesellschaft 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use
FR2703052B1 (fr) * 1993-03-26 1995-06-02 Pasteur Institut Nouvelle méthode de séquençage d'acides nucléiques.

Also Published As

Publication number Publication date
CA2190982A1 (en) 1995-12-07
WO1995032985A1 (de) 1995-12-07
EP0763051A1 (de) 1997-03-19
ZA954333B (en) 1996-11-26
DE4418691A1 (de) 1996-02-22

Similar Documents

Publication Publication Date Title
US6605611B2 (en) Base analogues
US4948882A (en) Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis
JP3119171B2 (ja) オリゴヌクレオチド−ポリアミド コンジュゲート
RU2073682C1 (ru) 3' и/или 2'-амино- или тиолмодифицированные нуклеозиды, нуклеотиды или олигонуклеотиды, способ получения соединений
Wojczewski et al. Fluorescent oligonucleotides-Versatile tools as probes and primers for DNA and RNA analysis
CN101605743A (zh) 用于产生报告分子的点击化学
WO2002002817A2 (en) Multipartite high-affinity nucleic acid probes
CN112218640A (zh) 核苷酸类似物及其在核酸测序和分析中的用途
JP4908714B2 (ja) ポリアミド核酸誘導体および薬剤、ならびにその調製方法
FR2632955A1 (fr) Derives de nucleosides utilisables pour la synthese d'oligonucleotides marques, oligonucleotides obtenus a partir de ces derives et leur synthese
US7345163B2 (en) Process for separating and deprotecting oligonucleotides
JP2002525288A (ja) ２重末端選択を用いるオリゴマーの精製
US6013434A (en) Oligonucleotide-polyamide conjugates
WO2008075718A1 (ja) 蛍光発生分子
JPH10500963A (ja) アミノカルボン酸、ペプチドまたはカルボン酸スペーサーを有する３’−（４’−）非放射性標識ヌクレオシドおよびヌクレオチド
WO2002074950A1 (fr) Procede d'analyse d'interaction intermoleculaire
Capasso et al. Solid phase synthesis of DNA-3′-PNA chimeras by using Bhoc/Fmoc PNA monomers
WO1993024511A1 (en) Oligonucleotide-polyamide conjugates
US5859259A (en) Activated esters of 1-phenylpyrazolin-5-one for labeling amine-functionalized molecules
JP3379774B2 (ja) 塩基配列決定方法
JP2723360B2 (ja) オリゴヌクレオチド−ポリアミドコンジュゲート
JPH03500169A (ja) 標識オリゴヌクレオチドの化学的製造方法及び生物学的使用
Dubey et al. Synthesis of 3'-and 3', 5'-modified oligonucleotides on functionalized silica Silochrom-2
JP2002107364A (ja) ノンラベル検出用生物試薬アレイ及びその作製方法
AU4054693A (en) Oligonucleotide-polyamide conjugates